Through our global networks across pharma, biotech, academia and finance, we pursue win/win partnerships to identify, acquire and accelerate the development and delivery of the most promising therapeutic programs to transform patients’ lives.
We leverage the global network of our team to identify the most promising assets using their cumulative development and commercial expertise.
We utilize our deep experience in business development to execute win-win licenses, partnerships or acquisitions that generate maximum value for ACELYRIN and our partners.
We design and implement development programs to reduce risks and accelerate timelines while maximizing therapeutic and commercial potential.
We can rapidly assemble teams and resources – including capital – required for efficient execution of the development, regulatory, manufacturing and commercial processes.
